KOCHEVAR KAREN sold $900K of CAVA

KOCHEVAR KAREN sold 10,000 shares of CAVA GROUP, INC. (CAVA) at $90.00 ($0.90M total) on 2026-06-18.

Original reporting
SEC EDGAR · KOCHEVAR KAREN
Published Jun 23, 2026, 8:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CAVA
Neutral
medium confidence
Mentioned
$CAVA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CAVANeutralLow
01

Why it matters

The newest fact is the director’s open-market sale of 10,000 shares for $900,000, which may influence short-term sentiment but does not change company fundamentals in the text.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale is unlikely to drive a durable repricing without additional catalysts.

03

What to watch

The filing lacks context on taxes, diversification needs, or whether other grants/sales occurred; absence of a 10b5-1 plan does not prove bearish intent.

Relevance 5/10Novelty 5/10Timing: new SEC Form 4 filed 2026-06-23 (sale dated 2026-06-18)

Background

The article is an SEC Form 4 insider transaction disclosure for CAVA Group, Inc.

Company-level read

Ticker impact

$CAVANeutralMedium confidence
Context

SEC Form 4 shows director Karen Kochevar sold 10,000 CAVA shares on 2026-06-18 for $900,000, with no 10b5-1 plan.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal from this single sale.

Evidence & confidence

The filing discloses an insider sale size/value and absence of a 10b5-1 plan, but provides no earnings, guidance, or operational change.

Market effects

Minimal; this is company-specific insider activity with no sector-wide datapoint.

None indicated.

None indicated.

Counterpoint

A director sale can be routine liquidity/portfolio rebalancing and does not necessarily reflect negative fundamentals.

Key entities

  • CAVA Group, Inc.

    Issuer of the Form 4 insider transaction; director Karen Kochevar sold shares.

  • Karen Kochevar

    Director who sold 10,000 shares on 2026-06-18; holdings after sale: 3,074 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CAVAHighAI 8/10

Cava Group Inc (CAVA) Q3 2026 Earnings Call Highlights: 500 Restaurants and 22% Revenue

Cava Group Inc (CAVA) reported Q3 2026 earnings with 22% revenue growth but lower margins and net income. Restaurant-level profit margin decreased to 23.4% from 24.6%, and net income fell to $13.2 million. Pre-opening expenses rose to $8.4 million. The company anticipates higher food costs in Q4 and faces external pressures like high gas prices. Management expects Q4 comps to range from 1.5% to 6%, with the midpoint as the most likely outcome.

$CAVAHighAI 8/10

Why CAVA (CAVA) shares are falling today

CAVA (NYSE: CAVA) shares fell 10.1% after reporting Q3 2026 revenue of $356.4M, missing estimates, and lowering full-year EBITDA guidance. Same-store sales grew 3.1%, down from prior-year levels. The company operates 500 restaurants. Investors reacted to decelerating growth and margin contraction.

$CAVAHighAI 8/10

CAVA Group shares slide 11% after missing estimates

CAVA Group's shares dropped 11% to $54.59 after Q3 earnings of $0.11 per share and revenue of $356.44 million missed estimates. Net income fell to $13.2 million, and profit margins narrowed. Same-restaurant sales growth slowed to 3.1%, partly due to food safety concerns. Despite this, the company raised its annual sales growth forecast and increased its restaurant opening target.

$CAVAHighAI 8/10

DA Davidson cuts Cava Group stock price target on margin pressure

DA Davidson reduced its price target for Cava Group (NYSE:CAVA) to $60 from $75, citing margin pressure and higher costs. The stock trades at $55.85 with a market cap of $7.24B. Q3 results missed expectations, but the company raised its 2026 same-store sales guidance. EBITDA guidance was lowered to $184M-$189M, below consensus. Other analysts also cut price targets post-earnings.

$CAVAMed

RBC cuts Cava stock price target on Q3 miss, maintains Outperform

RBC Capital cut its price target on Cava Group Inc. (NYSE:CAVA) to $80 from $85, maintaining an Outperform rating. The company's Q3 results missed estimates, with same-store sales growth of 3.1% below expectations. EBITDA missed by 4.7%, driven by lower revenue and higher expenses. Management expects 16% unit growth for fiscal 2027. The stock is down 31% over six months, trading at $56.48 with a P/E ratio of 124.